Creating a Powerful NAM respiratory Toxicology Strategy for Clinical Predictivity and IND success

During this fireside chat session, you will hear our 2 guest speakers discuss how to best devise a NAM (new approach methodologies) strategy to progress your respiratory compound through the pipeline including standardisation, trends and innovations in respiratory in-vitro models.

Speakers
Dr Clive Roper – Director – Roper Toxicology Consulting Limited

Dr Megan Webster – Head of Lung – Newcells Biotech

Watch the on demand from here